BMJ6d
Feasibility of a structured 3-minute walk test as a clinical decision tool for patients presenting to the emergency department with acute dyspnoea
The 3-minute walk test protocol was as follows: after a brief explanation of the protocol, including how to rate dyspnoea on the modified Borg scale, patients were asked to ambulate within the ED for ...
thorax.bmj4d
Expression of cilium-associated genes defines novel molecular subtypes of idiopathic pulmonary fibrosis
Clinical data include clinical and pathological diagnoses, chest CT images, pulmonary function tests (spirometry, D L CO and ABG), exposure (including cigarette smoking history) and symptom ...
CNET5d
Best Smart Scale for 2025
Determine if you'd like your smart scale to connect to Wi-Fi, Bluetooth or both. User-friendly interface You want a smart scale that has an interface that's easy to read and follow. Especially if ...
Medscape3d
Pulmonary Rehabilitation* Joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines
Results: The new evidence strengthens the previous recommendations supporting the benefits of lower and upper extremity exercise training and improvements in dyspnea and health-related quality-of ...
BMJ4d
Efficacy and safety of mavrilimumab in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial
Objectives Granulocyte-macrophage colony-stimulating factor (GM-CSF) is implicated in pathogenesis of giant cell arteritis. We evaluated the efficacy of the GM-CSF receptor antagonist mavrilimumab in ...
thorax.bmj5d
A randomised trial of domiciliary, ambulatory oxygen in patients with COPD and dyspnoea but without resting hypoxaemia
Patients underwent baseline measurements of arterial blood gases and lung function. Outcome measures assessed dyspnoea, health-related quality of life, mood disturbance, functional status and cylinder ...